Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
PPAR Res. 2007;2007:61563. doi: 10.1155/2007/61563.
Embryonic stem (ES) cells have great therapeutic potential because they are capable of indefinite self-renewal and have the potential to differentiate into over 200 different cell types that compose the human body. The switch from the pluripotent phenotype to a differentiated cell involves many complex signaling pathways including those involving LIF/Stat3 and the transcription factors Sox2, Nanog and Oct-4. Many nuclear receptors play an important role in the maintenance of pluripotence (ERRbeta, SF-1, LRH-1, DAX-1) repression of the ES cell phenotype (RAR, RXR, GCNF) and also the differentiation of ES cells (PPARgamma). Here we review the roles of the nuclear receptors involved in regulating these important processes in ES cells.
胚胎干细胞(ES 细胞)具有巨大的治疗潜力,因为它们能够无限自我更新,并有可能分化为组成人体的 200 多种不同的细胞类型。从多能表型到分化细胞的转变涉及许多复杂的信号通路,包括涉及 LIF/Stat3 和转录因子 Sox2、Nanog 和 Oct-4 的信号通路。许多核受体在维持多能性(ERRbeta、SF-1、LRH-1、DAX-1)、抑制 ES 细胞表型(RAR、RXR、GCNF)和 ES 细胞分化(PPARgamma)方面发挥着重要作用。在这里,我们回顾了核受体在调节 ES 细胞中这些重要过程中的作用。